J
JCR Pharmaceuticals Co Ltd
OTC:JCRRF
JCR Pharmaceuticals Co Ltd
OTC:JCRRF
Price:
5
USD
32.28%
Market Closed
Market Cap:
$648.5m
Relative Value
The Relative Value of one JCRRF stock under the Base Case scenario is 5.08 USD. Compared to the current market price of 5 USD, JCR Pharmaceuticals Co Ltd is Undervalued by 2%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JCRRF
Relative Value
Base Case
5.08
USD
Undervaluation 2%
J
Multiples Across Competitors
JCRRF Competitors Multiples
JCR Pharmaceuticals Co Ltd Competitors
JCR Pharmaceuticals Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
J
|
JCR Pharmaceuticals Co Ltd
OTC:JCRRF
|
75.9B USD | 2 | -31.1 | -30.5 | -13.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
944.6B USD | 14.5 | 45.8 | 30.9 | 32.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.1B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
253.8B CHF | 4.1 | 19.8 | 11.7 | 13.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.6B CHF | 5.3 | 21.4 | 13.2 | 17 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.4B GBP | 5.1 | 29.3 | 16.3 | 22.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
287.6B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.2B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.7B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
